Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started
Sign up to stay up to date with the stocks you care about
Follow SERA PROGNOSTICS, INC.

Get SEC filing alerts via email and in your feed for SERA PROGNOSTICS, INC.

SERA

SERA PROGNOSTICS, INC.

About SERA PROGNOSTICS, INC.

Sera Prognostics specializes in women’s health by developing blood-based biomarker tests and predictive analytics to improve pregnancy outcomes. Its core product, the PreTRM test, accurately predicts preterm birth risk, enabling proactive interventions. The company leverages proprietary proteomics, bioinformatics, and extensive biobanks to address unmet needs in maternal-fetal medicine, targeting healthcare providers, payers, and pregnant women worldwide.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from SERA PROGNOSTICS, INC.

1
1
2
1
3
1
4
1
5
1
6
1
7
1